OR WAIT null SECS
February 01, 2018
Cambrex invests in development and laboratory facilities and adds staff.
Avista Pharma's strengthens early phase drug development offerings with acquisition of Solid Form Solutions.
Chemical engineers and chemists each bring unique skills to API process development and optimization. Success depends on their close collaboration, at both sponsor and CDMO facilities.
January 25, 2018
Hovione has installed a new MG2 Tekna Precision Capsule filler at its Portugal site.
January 16, 2018
A ceremony was held at Cambrex’s Karlskoga facility to mark the commencement of a long-term manufacturing agreement with AstraZeneca for a key intermediate.
December 06, 2017
The contract research, development, and manufacturing organization has expanded API aseptic manufacturing capacity at its Valladolid, Spain, facility.
November 20, 2017
Avista Pharma Solutions facility and equipment upgrades at its Longmont, Colorado facility support processing of potent compounds.
November 02, 2017
Capsugel announced on Oct. 31, 2017 that it expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products using liquid-filled hard capsule technology, at its Edinburgh facility in Scotland.
Industry experts were honored for business, scientific, and social contributions.
October 24, 2017
The CDMO is investing £6 million into a new facility at its United Kingdom site to expand its milling, micronization, and solid form capabilities.